83 related articles for article (PubMed ID: 27031175)
1. Healing the damaged mesangium in nodular glomerulosclerosis using mesenchymal stem cells (MSCs): Expectations and challenges.
Herrera GA; Zeng C; Turbat-Herrera EA; Teng J
Ultrastruct Pathol; 2016; 40(2):61-70. PubMed ID: 27031175
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic plasticity of mesenchymal stem cells is crucial for mesangial repair in a model of immunoglobulin light chain-associated mesangial damage.
Herrera GA; Teng J; Zeng C; Xu H; Liang M; Alexander JS; Liu B; Boyer C; Turbat-Herrera EA
Ultrastruct Pathol; 2018; 42(3):262-288. PubMed ID: 29668344
[TBL] [Abstract][Full Text] [Related]
3. Animal Models of Light Chain Deposition Disease Provide a Better Understanding of Nodular Glomerulosclerosis.
Herrera GA; Turbat-Herrera EA; Teng J
Nephron; 2016; 132(2):119-36. PubMed ID: 26794829
[TBL] [Abstract][Full Text] [Related]
4. [Clinical pathology of the glomerulus--from phenomenon to entity. The nodular-lobular lesion].
Olsen S
Verh Dtsch Ges Pathol; 1989; 73():94-104. PubMed ID: 2482639
[TBL] [Abstract][Full Text] [Related]
5. Integrated expression of glomerular extracellular matrix proteins and beta 1 integrins in monoclonal light chain-related renal diseases.
Turbat-Herrera EA; Isaac J; Sanders PW; Truong LD; Herrera GA
Mod Pathol; 1997 May; 10(5):485-95. PubMed ID: 9160315
[TBL] [Abstract][Full Text] [Related]
6. Immunization against glomerular basement lamella and mesangial substance.
Fuchs U; Schade J; von Baehr R
Acta Histochem Suppl; 1986; 33():251-2. PubMed ID: 3090633
[TBL] [Abstract][Full Text] [Related]
7. Glomerular capillary aneurysms in light-chain nephropathy. An ultrastructural proposal of pathogenesis.
Sinniah R; Cohen AH
Am J Pathol; 1985 Feb; 118(2):298-305. PubMed ID: 3918454
[TBL] [Abstract][Full Text] [Related]
8. Glomerulopathic light chain-mesangial cell interactions modulate in vitro extracellular matrix remodeling and reproduce mesangiopathic findings documented in vivo.
Herrera GA; Russell WJ; Isaac J; Turbat-Herrera EA; Tagouri YM; Sanders PW; Picken MM; Dempsey S
Ultrastruct Pathol; 1999; 23(2):107-26. PubMed ID: 10369104
[TBL] [Abstract][Full Text] [Related]
9. A case of idiopathic nodular glomerulosclerosis mimicking diabetic glomerulosclerosis (Kimmelstiel-Wilson type).
Müller-Höcker J; Weiss M; Thoenes GH; Grund A; Nerlich A
Pathol Res Pract; 2002; 198(5):375-9. PubMed ID: 12092775
[TBL] [Abstract][Full Text] [Related]
10. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
Okada M; Takemura T; Yanagida H; Yoshioka K
Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
[TBL] [Abstract][Full Text] [Related]
12. Two types of glomerular lesion in non-amyloid immunoglobulin deposition disease: a case report of IgD-lambda myeloma.
Kubo Y; Morita T; Koda Y; Hirasawa Y
Clin Nephrol; 1990 Jun; 33(6):259-63. PubMed ID: 2115826
[TBL] [Abstract][Full Text] [Related]
13. Mesangial bridges. A mode of progression in diabetic glomerulosclerosis.
Watanabe T; Emoto K
Acta Pathol Jpn; 1981 Nov; 31(6):1045-51. PubMed ID: 7315309
[TBL] [Abstract][Full Text] [Related]
14. Constituents of the extracellular matrices in diabetic glomerulosclerosis.
Suzuki Y
Nihon Jinzo Gakkai Shi; 1989 Oct; 31(10):1047-54. PubMed ID: 2615016
[TBL] [Abstract][Full Text] [Related]
15. Essential mixed cryoglobulinemic glomerulonephritis associated with diabetic glomerulosclerosis. Light, immunofluorescence, and ultrastructural study of two cases.
Mazzucco G; Dogliani M; Castello R; Monga G
Arch Pathol Lab Med; 1985 Nov; 109(11):1036-9. PubMed ID: 3840355
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in progressive crescentic glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
[TBL] [Abstract][Full Text] [Related]
17. Diabetic nephropathy. Mechanisms of mesangial matrix expansion.
Abrass CK
West J Med; 1995 Apr; 162(4):318-21. PubMed ID: 7747496
[TBL] [Abstract][Full Text] [Related]
18. The mesangium as a target for glomerulopathic light and heavy chains: pathogenic considerations in light and heavy chain-mediated glomerular damage.
Keeling J; Herrera GA
Contrib Nephrol; 2007; 153():116-34. PubMed ID: 17075227
[TBL] [Abstract][Full Text] [Related]
19. Histological changes and immunohistochemical markers in the assessment of glomerulosclerosis in patients with glomerulonephritis.
Bob FR; Gluhovschi G; Herman D; Bozdog G; Gluhovschi C; Velciov S; Potencz E; Petrica L
Rom J Morphol Embryol; 2011; 52(3 Suppl):1027-32. PubMed ID: 22119820
[TBL] [Abstract][Full Text] [Related]
20. Cellular aspects of rabbit Masugi nephritis. III. Mesangial changes.
Kondo Y; Shigematsu H; Okabayashi A
Lab Invest; 1976 Apr; 34(4):363-71. PubMed ID: 1263440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
